NCT01528488View on ClinicalTrials.gov

Prophylactic EVOZAC® Calming Skin Spray for EGFR-TKIs Associated Rash Eruption in NSCLC

PHASE2/PHASE3CompletedINTERVENTIONAL
Enrollment

118

Participants

Timeline

Start Date

December 31, 2011

Primary Completion Date

June 30, 2013

Study Completion Date

July 31, 2013

Conditions
Non-small Cell Lung Cancer
Interventions
OTHER

EVOZAC Calming Skin Spray

EVOZAC Calming Skin Spray should be sprayed to the skin in the total face, three times per day

OTHER

Physiological saline

Physiological saline was used as the placebo of EVOZAC® Calming Skin Spray and should be also sprayed on the total face, three times per day

Trial Locations (1)

510060

Department of Medical Oncology,Cancer Center of Sun Yat-Sen University, Guangzhou

All Listed Sponsors
lead

Sun Yat-sen University

OTHER

NCT01528488 - Prophylactic EVOZAC® Calming Skin Spray for EGFR-TKIs Associated Rash Eruption in NSCLC | Biotech Hunter | Biotech Hunter